- Supply chain disruptions
- Counterfeit medicines
- Opioid crisis
- AMR
- Climate change impacts
- Water stress in some operating areas
- Maintaining ethical and compliant business practices
- Data privacy and security threats
Teva Pharmaceutical Industries Ltd
Greenhouse gas emissions & sustainability report data
In its 2022 reporting, Teva Pharmaceutical Industries Ltd disclosed greenhouse gas emissions of 498.6K tCO2e/year (Scope 1 & 2 in 2022). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
498.6K tCO2e/year (Scope 1 & 2 in 2022)
2022
Renewable Energy
41% of total energy use (2022)
of total energy
Water Usage
1.3K ML/year (Areas projected to be in water stress in 2022)
2022
Waste
111.2K metric tons/year (2022)
2022
✅ Reported Environmental Achievements
- 24% reduction in absolute scope 1 and 2 GHG emissions (vs. 2019)
- 12% reduction in absolute scope 3 GHG emissions (vs. 2020)
- Achieved 10% increase in energy efficiency by revenue (kWh/USD revenue) by 2030 (vs. 2020)
- Increased total proportion of electricity purchased or generated from renewable sources by 8% (vs. 2021) to 41%
- Achieved 17% reduction in total water withdrawal in areas projected to be in water stress by 2030 (vs. 2020)
- 32% reduction in total waste generated (vs. 2020) and 3% increase in proportion of waste recovered (vs. 2020)
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce absolute scope 1 and 2 GHG emissions by 25% by 2025 (vs. 2019)
- Train 100% of active employees on applicable Teva compliance policies by 2023
- Assess 100% of critical suppliers on ESG performance by 2025
📅 Medium-term
- Reduce absolute scope 1 and 2 GHG emissions by 46% by 2030 (vs. 2019)
- Reduce absolute scope 3 GHG emissions by 25% by 2030 (vs. 2020)
- Increase total proportion of electricity purchased or generated from renewable sources to 50% by 2030
- Reduce total water withdrawal by 10% in areas projected to be in water stress by 2030 (vs. 2020)
- Launch eight access programs by 2025
🔭 Long-term
- Net-zero emissions by 2050 (implied)
🌱 ESG Focus Areas
Climate Action and ResilienceResponsible Use of Natural ResourcesEffluents and WastePharmaceuticals in the EnvironmentAccess to Health and MedicinesInclusion and DiversityTalent Recruitment, Development and RetentionEmployee EngagementEmployee Health, Safety and Well-beingEconomic ImpactHuman RightsEthics and Transparency in Clinical TrialsCorporate GovernanceCompliance and EthicsResponsible LobbyingSustainable ProcurementQuality Manufacturing and Patient SafetyData Privacy and Security